DUBAI, United Arab Emirates, March 22, 2022 (GLOBE NEWSWIRE) -- The global Bipolar Disorder Drugs And Treatment Market share, which was anticipated to be worth US$5.9 billion in 2022, is expected to expand to US$6.8 billion by 2026, at a CAGR of 3.1 per cent throughout the forecast period. The growing incidence of bipolar disease, increased government attempts to raise awareness, and technology improvements are among the primary drivers driving bipolar disorder drug therapy.
The rising frequency of bipolar disorder, government assistance for raising awareness about the disorder, and technology improvements that allow for more precise detection of a patient's mood and mental state are just a few of the factors impacting bipolar disorder drug use. The use of tricyclic antidepressants, for example, has decreased over time due to a higher rate of side effects as compared to other medications used to treat bipolar illness.
| Attributes | Details | |
| Bipolar Disorder Drugs and Treatment Market CAGR (2022-2032) | 3% | |
| Bipolar Disorder Drugs and Treatment Market (2027) | US$ 7 Bn | |
| Bipolar Disorder Drugs and Treatment Market Attraction | Support from the government organizations to increase awareness about the bipolar disorder is the major factor driving the bipolar drugs market. | |
Request A Report Sample To Gain Comprehensive Insights At
https://www.futuremarketinsights.com/reports/sample/rep-gb-14407
As per the bipolar disorder drugs and treatment market study, governments in a number of countries are providing funds for bipolar disorder research and launching public awareness programs in order to reduce the stigma associated with the disease and increase treatment and adherence rates among the general public.
Scientific organizations and medical institutions are also actively involved in the treatment of bipolar disorder by conducting research studies and producing new medications for bipolar disorder drug therapy.
Technology advancements are also assisting bipolar disorder drugs and treatment market expansion, as the usage of smartphones, smartwatches, and wearable devices allows for accurate detection of a patient's emotional and mental state, as well as effective capture of physiological, behavioural, and environmental data.
Aside from that, the introduction of online self-management tools for mental illnesses allows for earlier intervention and greater adherence to prescribed drug treatments for bipolar disorders.
However, many of the medications for bipolar disorders include adverse effects such as drug addiction, diabetes and cholesterol difficulties, blurred vision, liver and thyroid damage, and more.
Furthermore, bipolar disorder is frequently misinterpreted as depression or personality disorder, lowering the diagnosis and treatment rates of this mental illness.
Obtaining special designation from regulatory bodies is a key aspect in the bipolar disorder drugs and treatment market.
Other factors driving market growth include rising expenditure on healthcare infrastructure development, rising adoption of a sedentary lifestyle, increased government initiatives to promote awareness in underserved areas, and an increase in the strategic collaboration rate among market players. Another variable that will provide profitable bipolar disorder therapeutics market growth potential is society's increasing acceptance of mental illness.
However, in developing and underdeveloped nations, a scarcity of competent medical personnel and an unfavourable reimbursement scenario would constitute a significant impediment to market expansion.
For Any Queries Related With The Report, Ask An Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-14407
Scope of the Report
| Attributes | Bipolar Disorder Drugs and Treatment Market | Anti-mania Drugs Market | Behavioral Health Market | |||
| CAGR (2022 - 2032) | 3% | 10.2% | 7.6% | |||
| Market Value (2027) | US$ 7 Bn | US$ 22 Bn | US$ 42.3 Bn | |||
| Growth Factor | Growing Awareness about the effectiveness of drugs in treating bipolar disorders have increased its demand. | By the support of government and international organizations mental disorder drugs are getting affordable and available in the market | Alcohol overuse disorders are getting more common in recent times and requiring most of the behavioral health market drugs. | |||
| Opportunity | In Asia Pacific region the bipolar disorder cases are growing with the rapid urbanization with a great opportunity for market players. | Innovative drugs discovered in the field of psychiatric disease have come up with new effective medicines for mental health. | Emergency mental health services require sedatives as a precaution to deteriorating condition of patients growing the demand for it. | |||
| Key Trends | With the rationalization of drug regulations the sale of bipolar medicine on online platforms have increased. | Increasing number of clinical tests is rising the count of mental disorder cases growing the demand for such drugs. | With the starting of home based treatment services for behavioral health patients the sale of drugs on online platforms have increased. | |||
High costs associated with research and development capabilities, side effects such as blurred vision, liver damage, and thyroid disorders, stringent regulatory frameworks, a limited number of approved anticonvulsants, and poor healthcare facilities in developing economies will all contribute to the slow demand for bipolar disorder drugs and treatment.
Key Takeaways
- North America is observed to possess a considerable proportion of the bipolar disorder drugs and treatment market and is predicted to maintain this trend over the projection period, with minor fluctuations.
- After a detailed examination of the pandemic's commercial ramifications and the resulting economic crisis, the Anticonvulsants segment's growth is revised to a revised 3.9 per cent CAGR for the next seven years. This group now has 21.8 per cent of the bipolar disorder therapeutics market. In the United States, the market for drug treatment of bipolar disorders is expected to reach US$2.6 billion by 2022. The country presently holds 44.35 per cent of the worldwide market share.
- China, the world's second-largest economy, is expected to reach a market size of US$513.9 million in 2026, representing a CAGR of 4.8 per cent over the study period.
We Offer Tailor-Made Solutions To Fit Your Requirements, Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-14407
Competitive Landscape
Due to the presence of small and major market players, the industry analyzed is fairly consolidated. Allergan PLC, Otsuka Holdings Co. Ltd, AstraZeneca Plc, Eli Lilly and Company, AbbVie Inc., Pfizer Inc., GlaxoSmithKline Plc, Novartis AG, and Janssen Pharmaceuticals Inc. are some of the key players.
North America dominates the global bipolar disorder drugs and treatment market, thanks to widespread knowledge of the disease, the presence of major businesses, technical advancements, a robust healthcare system, and an increasing number of bipolar disorder cases. Asia, headed by India and China, is predicted to be the fastest-growing market, owing to the rising prevalence of mental disorders, increased awareness of bipolar disorders, and increased investments by major corporations.
Explore FMI’s Extensive ongoing Coverage on Healthcare Domain
Anti-Malarial drugs Market - Anti-malarial drugs are the medicines used to prevent and treat malaria. The malaria is the disease caused due to the parasite known as Plasmodium, belongs to the organism group Protozoa.
Antiepileptic Drugs Market - Antiepileptic drugs market are usually referred as anti-seizure drugs market, which is developed as a part of the asymptomatic and Idiopathic treatment of epileptic seizures.
Depression Drugs Market - Depression is a serious mood disorder which causes a persistent feeling of sadness and loss of interest thus affecting daily routine activities such as sleeping, walking, talking, thinking, eating etc.
Erectile Dysfunction Drugs Market - Erectile dysfunction also known as impotence is the state of sexual dysfunction where men cannot maintain erection during sexual intercourse. Erectile dysfunction mainly caused by chronic diseases like diabetes, cardiovascular diseases, neurological issues and hormonal insufficiency and drug side effects.
Antithrombotic Drugs Market - Antithrombotic drugs are known as an agent which reduces the formation of thrombus or clot in the blood. A thrombus or clot is formed at the site of injuries, which can be a simple skin injury or the major intravascular injury.
Muscle Relaxant Drugs Market - Muscle relaxant drugs are primarily used in conjunction with general anesthetics to achieve muscle relaxation during surgical interventions.
Veterinary Pain Management Drugs Market - Veterinary pain management is a very important aspect of veterinary therapeutics. Animals suffer from pain, sometimes chronic, but however are unable to express it. Pain in animals could be associated with surgical pain, arthritis and cancer.
Anti-Viral Drugs Market - Anti-viral drugs are medicines which are used specially for treating viral infections. Most anti-viral drugs are used for particular viral infections, similar to antibiotics, while a broad-spectrum anti-viral drug is effective against a varied range of viruses.
Glioblastoma Treatment Drugs Market - Brain tumors is one of the leading cause of cancer which is common among children and teenagers. Glioblastoma (GBM) is most common grade four tumor, is malignant and contains dead tumor cells.
Systemic Lupus Erythematous SLE Drugs Market - The systemic lupus erythematosus (SLE) drugs market is projected to record a CAGR of 5% during the forecast period, up from US$ 183.3 Bn in 2020, to reach a valuation of US$ 329.18 Bn by 2032.
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/
Report: https://www.futuremarketinsights.com/reports/bipolar-disorder-drugs-and-treatment-market
